Pharmacology and Pharmaceutical Sciences articles for Massachusetts Institute of Technology (MIT), United States of America (USA)

Time frame: 1 June 2025 - 30 May 2026
Count: 36

Article ‘Count’ for Pharmacology and Pharmaceutical Sciences.

Journal Count Share
2 1.05
Anti-Aggregation System for the Enhanced Transdermal Delivery of Cell Membrane-Coated Nanoparticles 0.05
Manufacturing mRNA-Loaded Lipid Nanoparticles with Precise Size and Morphology Control 1.00
1 0.08
Gastrointestinal distribution of engineered biodegradable urease-powered nanomotors 0.08
2 1.01
High Concentration Antibody Formulations Enabled via Thermostable Ionic Liquids 0.01
High‐Concentration Antibody Formulation via Solvent‐Based Dehydration 1.00
1 0.96
Surface Avidity of Anionic Polypeptide Coatings on Layer‐by‐Layer Nanoparticles Target Cancer‐Associated Amino Acid Transporters 0.96
1 0.17
A context-augmented large language model for accurate precision oncology medicine recommendations 0.17
1 0.04
Inhibition of mTOR Enhances the Efficacy of Proteasome-Dependent Targeted Protein Degradation Approaches 0.04
2 1.33
A machine learning-based workflow for transaminase selection 0.33
Data-driven recommendation of agents, temperature, and equivalence ratios for organic synthesis 1.00
1 1.00
Hydrolysis Reaction Rate Prediction Using Machine Learning: WaterDRoP 1.00
1 0.01
Glucagon-like peptide-1 receptor agonists reduce experimental atherosclerosis progression, inflammatory biomarkers and cardiovascular events, irrespective of hyperglycaemia and obesity 0.01
1 0.03
Gestational Weight Gain and Pregnancy Outcomes After GLP-1 Receptor Agonist Discontinuation 0.03
5 2.57
Identifying Dynamic Metal–Ligand Coordination Modes with Ensemble Learning 1.00
Development of FBXO22 Degraders and the Recruitment Ligand 2-Pyridinecarboxyaldehyde (2-PCA) 0.04
Accurately Predicting Solubility Curves via a Thermodynamic Cycle, Machine Learning, and Solvent Ensembles 0.80
Phosphorylation-Inducing Molecules for Regulating Dynamic Cellular Processes 0.33
Developing Pharmaceutically Relevant Pd-Catalyzed C–N Coupling Reactivity Models Leveraging High-Throughput Experimentation 0.40
1 0.12
Expanding the druggable zinc-finger proteome defines properties of drug-induced degradation 0.12
1 0.53
Polymer Blend Controls Nanoparticles’ Surface Charge for Improved Mucus Penetration and Epithelial Cell Adhesion 0.53
1 0.00
Manufacturing-aware generative models enable petascale synthesis of designed DNA 0.00
2 0.05
Pharmacological targeting of IRF4 as a therapeutic strategy for multiple myeloma 0.01
Charged molecular glue discovery enabled by targeted degron display 0.04
4 2.33
Counting cells can accurately predict small-molecule bioactivity benchmarks 0.16
Bioresorbable RFID capsule for assessing medication adherence 0.77
Reference-based chemical-genetic interaction profiling to elucidate small molecule mechanism of action in Mycobacterium tuberculosis 0.39
Data-driven organic solubility prediction at the limit of aleatoric uncertainty 1.00
1 0.13
Real-time dynamic polygenic prediction for streaming data 0.13
1 0.02
Hypervariable loop profiling decodes sequence determinants of antibody stability 0.02
1 0.11
Pediatric studies and labeling additions required by the U.S. FDA for novel drugs approved from 2011 to 2023: A retrospective cohort study 0.11
2 2.00
Tyrosine phosphoproteome profiling identifies cell-intrinsic signals limiting the efficacy of tyrosine kinase inhibitor therapies 1.00
Graph neural networks for predicting metal–ligand coordination of transition metal complexes 1.00
1 0.06
Active learning framework leveraging transcriptomics identifies modulators of disease phenotypes 0.06
1 0.08
Functional and epitope specific monoclonal antibody discovery directly from immune sera using cryo-EM 0.08
1 0.52
Vaccines combining slow release and follicle targeting of antigens increase germinal center B cell diversity and clonal expansion 0.52
1 0.03
Benzodiazepine or Z-hypnotic use during pregnancy and risk of psychiatric disorders in children: population based cohort study 0.03

Numerical information only (in the tables above) is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International.